---
title: "Okta’s Stock Triples on 11% Revenue Growth and New-Product Momentum"
slug: "oktas-stock-triples-on-11-revenue-growth-and-new-product-momentum"
date: "2026-10-04"
category: "MarTech"
author: "Chloe Duval"
correspondent: "Chloe Duval"
correspondentRole: "GTM & Outbound Investigative Reporter"
readingTimeMinutes: 1
tags: ["MarTech","News"]
originalSourceUrl: "https://www.saastr.com/okta-tripled-on-11-growth-5-interesting-learnings-from-one-of-the-biggest-re-ratings-in-b2b-this-year-14-crpo-growth-30-of-bookings-from-new-products-and-50x-forward-earnings/"
canonicalUrl: "https://aurav.ae/oktas-stock-triples-on-11-revenue-growth-and-new-product-momentum"
publisher: "Aura-V Intelligence (aurav.ae)"
---

# Okta’s Stock Triples on 11% Revenue Growth and New-Product Momentum

> Okta’s shares surged three-fold in five months as 11% Q2 growth, a 14% cRPO rise and new products drove a re-rating.

## Key Takeaways (TL;DR)

- Okta’s stock rose from $62.66 to $195.19, a three-fold increase in five months despite modest revenue growth.
- Forward-earnings multiple jumped from ~18x to ~50x while cRPO accelerated to 14% and new products made up 30% of bookings.
- The company’s AI-agent kill switch, standards alliance and enterprise-focused bookings underpin the valuation lift.

Okta’s shares closed at $195.19 on Friday, a three-fold rise from the $62.66 52-week low recorded in April, while Q2 revenue grew 11% and subscription revenue 12% [Jason Lemkin, SaaStr](https://www.saastr.com/okta-tripled-on-11-growth-5-interesting-learnings-from-one-of-the-biggest-re-ratings-in-b2b-this-year-14-crpo-growth-30-of-bookings-from-new-products-and-50x-forward-earnings/). The company guided Q3 revenue to $813-$817 million, a 10% year-over-year increase.

Our read: The stock’s surge stems largely from valuation expansion. The forward-earnings multiple rose from roughly 18x to about 50x, while the EPS guide moved only ~2% to $3.90-$3.94. Forward-book metrics, especially cRPO, accelerated from 12% to 14% in Q2, signaling stronger pipeline despite flat revenue growth.

Our read: New-product sales now represent 30% of bookings, lifting average contract value by roughly 40% when attached. Identity Governance, Privileged Access and AI-agent offerings drove this share, with dozens of AI deals closed in Q2, including a multi-million-dollar healthcare contract.

---

*Original Think-Tank Source: [Why Okta Tripled on … 11% Growth. 5 Interesting Learnings From One of the Biggest Re-Ratings in B2B This Year: 14% cRPO Growth, 30% of Bookings From New Products, and ~50x Forward Earnings](https://www.saastr.com/okta-tripled-on-11-growth-5-interesting-learnings-from-one-of-the-biggest-re-ratings-in-b2b-this-year-14-crpo-growth-30-of-bookings-from-new-products-and-50x-forward-earnings/)*
